Long-Term Efficacy of Vagus Nerve Stimulation in Managing Drug-Resistant Epilepsy

Strategic Insights -

Research conducted at the Universita Cattolica del Sacro Cuore in Rome, Italy, has revealed the long-term benefits of vagus nerve stimulation (VNS) in managing drug-resistant epilepsy. A study involving 105 adult patients found that 80.8% of participants experienced significant reductions in seizure frequency over an average follow-up period of 9.4 years. The study's findings highlight the potential of VNS as a viable long-term treatment option for patients with drug-resistant epilepsy, significantly enhancing patient outcomes and quality of life.

Key Takeaways:

  • The study involved 105 adult patients with drug-resistant epilepsy who were treated with vagus nerve stimulation (VNS) at Agostino Gemelli Hospital between 1994 and 2022.
  • Among the 73 patients with follow-up data, 80.8% experienced significant reductions in seizure frequency over an average follow-up period of 9.4 years.
  • 19.2% of patients did not respond to VNS, but many of these patients still opted for generator replacements due to improvements in quality of life.
  • The overall complication rate was 12.3%, with most complications being mild and manageable.
  • The study's findings suggest that VNS offers substantial long-term benefits for patients with drug-resistant epilepsy, improving seizure control and quality of life.
  • The authors of the study highlight the importance of VNS as a viable long-term treatment option for patients with drug-resistant epilepsy.

Statistics:

  • 105 patients with drug-resistant epilepsy were treated with VNS at Agostino Gemelli Hospital between 1994 and 2022.
  • 73 patients had follow-up data, with 80.8% experiencing significant reductions in seizure frequency.
  • 19.2% of patients did not respond to VNS therapy.
  • The average follow-up period was 9.4 years for responders.
  • The overall complication rate was 12.3%.

Sources:

  • "Long-Term Outcome in Adult Patients with Drug-Resistant Epilepsy Submitted to Vagus Nerve Stimulation" (Brain Sciences, 2024,14(7))
  • Universita Cattolica del Sacro Cuore (Rome, Italy)
  • MDPI AG (publisher for Brain Sciences)